Title
Category
Credits
Event date
Cost
ALAHOPE Recorded Course - Substance Use Disorder in the Emergency Department
  • ALAHOPE Substance Use
  • 0.90 ABN
  • 0.75 ABSWE
  • 0.75 ACPE Pharmacy
  • 0.75 ACPE Technician
  • 0.75 ABO
  • 0.75 ABP
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
  • 0.75 BDEA
$0.00
An interactive, online training session substance use disorders within emergency healthcare settings.
ALAHOPE Recorded Course - Substance Use Disorder and Associated Co-Morbidities
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 ACPE Technician
  • 0.25 ABO
  • 0.25 ABP
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session explaining co-occurring conditions that often coincide with substance use disorder.
Recorded 2025 LIVE @ LUNCH - When Sleep Goes Wrong: Understanding Insomnia and Narcolepsy
  • Live @ Lunch
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
$25.00
This presentation will provide an update on the management of sleep disorders, specifically insomnia and narcolepsy. Sleep disorders have bi-directional relationships with many other co-occuring conditions; they may both impact and be impacted by these co-occuring conditions and related pharmacotherapy. Management approaches are limited overall, and become more limited when considering certain patient specific variables.
ALAHOPE Recorded Course - Substance Use in the US
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 ACPE Technician
  • 0.25 ABO
  • 0.25 ABP
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the history, current state, and impact of substance use in the U.S. particularly focusing on opioid use and related polydrug use.
Understanding Pharmacy Laws and Rules Governing the Health System and Hospitals in Alabama
  • Law
  • 0.75 ACPE Pharmacy
$25.00
This CE presentation reviews Alabama-Specific pharmacy laws, rules, and regulations relevant to health-system and hospital settings which are important for a pharmacist to know and for review of the MPJE.
Understanding Federal Pharmacy Law
  • Law
  • 1.00 ACPE Pharmacy
$25.00
This CE presentation reviews federal pharmacy laws, rules, and regulations important for a pharmacist to know and for review of the MPJE.
Recorded - The Efficacy, Safety, and Overuse of Ceftriaxone: An Antimicrobial Stewardship Discussion
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This program provides a comprehensive overview of ceftriaxone, focusing on its mechanism of action, spectrum of activity, and key pharmacokinetic and pharmacodynamic properties. Participants will learn about its major adverse effects, drug interactions, and clinical uses, with a special focus on recent reports of adverse events in Alabama. The discussion will emphasize the importance of antimicrobial stewardship in preventing the overuse of ceftriaxone and ensuring safe, effective treatment.
Treatment of Clostridioides difficile Infection
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This program will describe the risk factors associated with C. difficile infection (CID) and will focus on the current recommended treatment options, both pharmacotherapy and non-pharmacotherapy.  Additionally, the program will discuss new options that have recently come to the market for the treatment and prevention of CDI.
Recorded Treatment of Skin and Soft Tissue Infections (SSTIs), Diabetes-related Foot Infections (DFIs) and Osteomyelitis
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.80 ABN
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™
$0.00
Skin and soft tissues infections, diabetes-related foot infections, and osteomyelitis are frequently occurring infections among patients in both the inpatient and outpatient settings. Appropriate classification of these infections and recognition of the corresponding common causative pathogen are essential to determine optimal empiric antimicrobial therapy. This presentation will review types of SSTI and osteomyelitis along with common pathogens and discuss aspects of antimicrobial therapy for treatment of SSTI and osteomyelitis, including dosing, route, monitoring parameters and duration.
Recorded Treatment of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.80 ABN
  • 1.50 ACPE Pharmacy
  • 1.50 AMA PRA Category 1 Credit™
$0.00
Urinary tract infections (UTIs) are one of the most common indications for receipt of antimicrobial therapy in both the community, hospital, and long-term care settings.  However, inappropriate use of broad-spectrum antibiotics for the treatment of UTIs has significantly contributed to the development of antimicrobial resistance to UTI pathogens.

Pages